Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shenghua Kelly Fan"'
Autor:
Shenghua Kelly Fan
Publikováno v:
Journal of Data Science. 7:331-347
This paper proposes a parametric method for estimating animal abundance using data from independent observer line transect surveys. This method allows measurement errors in distance and size, and less than 100% detection rates on the transect line. B
Autor:
Ying Lu, Shenghua Kelly Fan
Publikováno v:
Statistics in Biopharmaceutical Research. 4:324-335
Most phase II cancer trials evaluate total response (TR) rate using a single-arm open-label design. Simon's two-stage design minimizes either the expected or the total number of patients. In this article, we investigate the distribution of time to re
Autor:
Bee Leng Lee, Shenghua Kelly Fan
Publikováno v:
Journal of Biopharmaceutical Statistics. 22:802-818
Existing algorithms for identifying the maximum tolerated combination in dose-finding trials of two agents are mostly one-dimensional. Moreover, these algorithms use only the frequency of observed dose-limiting toxicities as the basis for dose escala
Autor:
Kathryn Chaloner, Shenghua Kelly Fan
Publikováno v:
Journal of Statistical Planning and Inference. 126:347-360
Designs for the continuation-ratio model for a trinomial response will be described. For the situation where the three response categories are: “no response”, “efficacy” and “adverse reaction”, both D-optimal designs and c-optimal designs
Autor:
Shenghua Kelly Fan, Kathryn Chaloner
Publikováno v:
Journal of Statistical Planning and Inference. 113:249-257
If a candidate c-optimal design gives a singular information matrix, an equivalence theorem from Silvey (1978) can be used to verify optimality. The theorem is difficult to use however, as it requires a generalized inverse of the information matrix b
Publikováno v:
Journal of biopharmaceutical statistics. 19(3)
Combination therapy of two antitumor agents may provide treatment additivity or synergy. Phase I trials for combination therapy search for the maximum tolerated dose (MTD) for combined agents. The conventional approach is to preselect an escalation p